Unique ID issued by UMIN | UMIN000041840 |
---|---|
Receipt number | R000045397 |
Scientific Title | Effect of ninjin'yoeito on the skeletal muscle mass in gastric cancer patients: a multicenter randomized controlled trial |
Date of disclosure of the study information | 2020/10/01 |
Last modified on | 2022/01/27 10:55:28 |
Effect of ninjin'yoeito on the skeletal muscle mass in gastric cancer patients: a multicenter randomized controlled trial
Effect of ninjin'yoeito on the skeletal muscle mass in gastric cancer patients
Effect of ninjin'yoeito on the skeletal muscle mass in gastric cancer patients: a multicenter randomized controlled trial
Effect of ninjin'yoeito on the skeletal muscle mass in gastric cancer patients
Japan |
Gastric cancer
Gastrointestinal surgery |
Malignancy
NO
To investigate the effect of Ninjin'yoeito on skeletal muscle mass in gastric cancer patients
Efficacy
Exploratory
Pragmatic
Phase II
Change of the ratio of skeletal muscle mass to body weight
(1) Change of body composition
(2) Change of nutritional parameters
(3) Adverse events and postoperative complications
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
No treatment
NO
NO
Institution is considered as a block.
YES
Central registration
2
Treatment
Medicine |
No medication
Kracie Ninjin'yoeito Extract Granules, 7.5g per day
20 | years-old | <= |
Not applicable |
Male and Female
1) Histologically confirmed clinical stage I-III gastric cancer
2) At least one of the following symptoms: decreased strength after illness, fatigue/malaise, anorexia, night sweats, cold limbs or anemia
3) Age of 20 years or older
4) Eastern Cooperative Oncology Group performance status of 0-2
5) Sufficient oral intake
6) Written informed consent
1) Patients scheduled to preoperative chemotherapy and/or radiotherapy
2) Any Japanese herbal medicine within 4 weeks before the commencement of the study
3) Allergy to Japanese herbal medicine
4) Severe comorbidities, such as liver disease, renal disease, heart disease, lung disease, hematologic disease and metabolic disease
5) Electrolyte abnormalities
6) Cardiac pacemaker
7) Severe mental disorder
8) Pregnancy
9) Patient who is judged to be unsuitable for inclusion in the study by the investigators
52
1st name | Sohei |
Middle name | |
Last name | Matsumoto |
Nara Medical University
Surgery
634-8522
840 Shijo-cho, Kashihara, Nara, 634-8522, Japan
0744-29-8863
msohei@naramed-u.ac.jp
1st name | Sohei |
Middle name | |
Last name | Matsumoto |
Nara Medical University
Surgery
634-8522
840 Shijo-cho, Kashihara, Nara, 634-8522, Japan
0744-29-8863
msohei@naramed-u.ac.jp
Department of Surgery, Nara Medical University
Department of Surgery, Nara Medical University
Self funding
Japan
Ethics Committee on Clinical Investigation of Nara Medical University
840 Shijo-cho, Kashihara, Nara, Japan
0744-22-3051
ino_rinri@naramed-u.ac.jp
NO
奈良県立医科大学附属病院、奈良県西和医療センター、南奈良総合医療センター
2020 | Year | 10 | Month | 01 | Day |
Unpublished
No longer recruiting
2020 | Year | 04 | Month | 01 | Day |
2020 | Year | 09 | Month | 02 | Day |
2020 | Year | 09 | Month | 18 | Day |
2023 | Year | 08 | Month | 31 | Day |
2020 | Year | 09 | Month | 18 | Day |
2022 | Year | 01 | Month | 27 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045397